These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3279968)

  • 21. Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport.
    Dullaart RP; van Tol A
    Diabet Med; 2001 Jun; 18(6):509-13. PubMed ID: 11472472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High density lipoprotein subfractions in relation to lipoprotein lipase activity of tissues in man--evidence for reciprocal regulation of HDL2 and HDL3 levels by lipoprotein lipase.
    Taskinen MR; Nikkilä EA
    Clin Chim Acta; 1981 May; 112(3):325-32. PubMed ID: 7237831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia.
    Hadigan C; Liebau J; Torriani M; Andersen R; Grinspoon S
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4438-44. PubMed ID: 16940448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of acipimox in patients with type 2 diabetes and persistent hyperlipidaemia.
    Dean JD; McCarthy S; Betteridge DJ; Whately-Smith C; Powell J; Owens DR
    Diabet Med; 1992; 9(7):611-5. PubMed ID: 1511566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase.
    Patsch JR; Prasad S; Gotto AM; Patsch W
    J Clin Invest; 1987 Aug; 80(2):341-7. PubMed ID: 3611351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequence of alcohol-induced initial changes in plasma lipoproteins (VLDL and HDL) and lipolytic enzymes in humans.
    Taskinen MR; Välimäki M; Nikkilä EA; Kuusi T; Ylikahri R
    Metabolism; 1985 Feb; 34(2):112-9. PubMed ID: 3969013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol.
    Blades B; Vega GL; Grundy SM
    Arterioscler Thromb; 1993 Aug; 13(8):1227-35. PubMed ID: 8343498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in serum lipids, lipoproteins, and heparin releasable lipolytic enzymes during moderate physical training in man: a longitudinal study.
    Peltonen P; Marniemi J; Hietanen E; Vuori I; Ehnholm C
    Metabolism; 1981 May; 30(5):518-26. PubMed ID: 7231189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel.
    Tikkanen MJ; Nikkilä EA; Kuusi T; Sipinen SU
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1113-7. PubMed ID: 7076794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of alcohol dose on plasma lipoprotein subfractions and lipolytic enzyme activity in active and inactive men.
    Hartung GH; Foreyt JP; Reeves RS; Krock LP; Patsch W; Patsch JR; Gotto AM
    Metabolism; 1990 Jan; 39(1):81-6. PubMed ID: 2104642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes.
    Taskinen MR; Kuusi T; Helve E; Nikkilä EA; Yki-Järvinen H
    Arteriosclerosis; 1988; 8(2):168-77. PubMed ID: 3279941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acipimox in the treatment of patients with hyperlipidaemia: a double blind trial.
    Ball MJ; Vella M; Rechlass JP; Jones DB; Stirling C; Mann JI; Galton D
    Eur J Clin Pharmacol; 1986; 31(2):201-4. PubMed ID: 3803417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, a new inhibitor of lipolysis.
    Sirtori CR; Gianfranceschi G; Sirtori M; Bernini F; Descovich G; Montaguti U; Fuccella LM; Musatti L
    Atherosclerosis; 1981; 38(3-4):267-71. PubMed ID: 7225165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of a phase IV study carried out with acipimox in type II diabetic patients with concomitant hyperlipoproteinaemia.
    Lavezzari M; Milanesi G; Oggioni E; Pamparana F
    J Int Med Res; 1989; 17(4):373-80. PubMed ID: 2676653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma.
    Freeman DJ; Caslake MJ; Griffin BA; Hinnie J; Tan CE; Watson TD; Packard CJ; Shepherd J
    Eur J Clin Invest; 1998 Jul; 28(7):584-91. PubMed ID: 9726040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults.
    Nielsen S; Møller N; Pedersen SB; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3274-8. PubMed ID: 12107236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fenofibrate for the treatment of type IV and V hyperlipoproteinemias: a double-blind, placebo-controlled multicenter US study.
    Goldberg AC; Schonfeld G; Feldman EB; Ginsberg HN; Hunninghake DB; Insull W; Knopp RH; Kwiterovich PO; Mellies MJ; Pickering J
    Clin Ther; 1989; 11(1):69-83. PubMed ID: 2655907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid decrease in high density lipoprotein subfractions and postheparin plasma lipase activities after cessation of chronic alcohol intake.
    Välimäki M; Nikkilä EA; Taskinen MR; Ylikahri R
    Atherosclerosis; 1986 Feb; 59(2):147-53. PubMed ID: 3964341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma lipoproteins and lipolytic enzyme activities during endurance training in sedentary men: changes in high-density lipoprotein subfractions and composition.
    Stubbe I; Hansson P; Gustafson A; Nilsson-Ehle P
    Metabolism; 1983 Dec; 32(12):1120-8. PubMed ID: 6417447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of fenofibrate on high-density lipoprotein particle size in patients with hyperlipidemia: a randomized, double-blind, placebo-controlled, multicenter, crossover study.
    Sasaki J; Yamamoto K; Ageta M
    Clin Ther; 2002 Oct; 24(10):1614-26. PubMed ID: 12462290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.